What is Affymax, Inc. (AFFY) stock price today?

Affymax, Inc. (AFFY) is currently trading at $0.00.

What is AFFY P/E ratio?

Affymax, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is AFFY return on equity (ROE)?

Affymax, Inc.'s return on equity (ROE) is 111.59%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Affymax, Inc.'s market cap?

Affymax, Inc. has a market capitalization of $37490.

OTC · Biotechnology

Affymax, Inc. (AFFY) Stock

$0.00 OTC: AFFY Healthcare

Affymax, Inc. presently lacks any substantial operational activities.

Valuation

Metric	Value
Price	$0.00
Market Cap	$37490
P/E Ratio	0.00
P/B Ratio	0.01
P/S Ratio	0.89
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	111.59%
ROA	-228.91%
ROCE	750.00%
Gross Margin	497.62%
Operating Margin	-1500.00%
Net Margin	-1400.00%
Debt/Equity	0.00
Current Ratio	20.81

Annual Financials (USD)

Metric	2009	2010	2011	2012	2013
Revenue	$115.0M	$113.0M	$48.0M	$94.0M	$1.0M
Operating Profit	$-79.0M	$-14.0M	$-61.0M	$-92.0M	$-15.0M
Net Profit	$-77.0M	$-14.0M	$-61.0M	$-93.0M	$-14.0M
EPS	$-4.06	$-0.57	$-1.84	$-2.57	$-0.39
Op Margin	-68.7%	-12.8%	-128.7%	-97.5%	-1099.0%

Balance Sheet (USD)

Metric	2009	2010	2011	2012	2013
Total Assets	$212.0M	$131.0M	$119.0M	$118.0M	$7.0M
Total Liabilities	$145.0M	$59.0M	$43.0M	$110.0M	$9.0M
Cash	$125.0M	$63.0M	$54.0M	$68.0M	$6.0M
Borrowings	$9.0M	$0	$0	$9.0M	$0

Cash Flow (USD)

Metric	2009	2010	2011	2012	2013
Operating Cash Flow	$-81.0M	$-49.0M	$-72.0M	$-37.0M	$-67.0M
Investing Cash Flow	$48.0M	$-12.0M	$7.0M	$21.0M	$14.0M
Financing Cash Flow	$0	$0	$0	$12.0M	$0
Net Cash Flow	$101.0M	$-62.0M	$-9.0M	$14.0M	$-63.0M
Free Cash Flow	$-82.0M	$-50.0M	$-73.0M	$-41.0M	$-67.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.39
FCF Yield	-179618.56%
Quick Ratio	0.71
Interest Coverage	-9.61
Return 1Y	25.00%
Return 3Y	-76.74%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Ancora Advisors, LLC	500	2023-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AMBSAmarantus BioScience Holdings, Inc.	$0.00	—	-0.01	$36841	0.00%
BSSPBaseline Productions, Inc.	$0.00	—	-0.02	$74377	0.00%
CNBXCNBX Pharmaceuticals Inc.	$0.00	—	0.10	$9251	0.00%
ENDVEndonovo Therapeutics, Inc.	$0.00	—	1.00	$31875	0.00%
GNLKQGeneLink, Inc.	$0.00	—	0.00	$10601	0.00%

About Affymax, Inc.

Affymax, Inc. presently lacks any substantial operational activities. In its earlier history, the firm concentrated on the creation of pharmaceutical agents designed to improve therapies for severe and frequently fatal health issues across the United States. Established in 2001, its corporate base is situated in New York, New York.

Affymax, Inc. (AFFY) stock trades at $0.00 with a market capitalization of $37490. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.01, price-to-sales of 0.89. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Affymax, Inc. generates a return on equity (ROE) of 111.59% — well above the market average, a sign of a high-quality business, return on capital employed of 750.00%, an operating margin of -1500.00%, a net profit margin of -1400.00%.

Official website: www.affymax.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides